LYKOS THERAPEUTICS

Prescription psychotropic drugs; Midomafetamine (MDMA) preparations for medical purposes; Pharmaceutical preparations for managing and treating mental illnesses and psychiatric, psychological, and neurological disorders and conditions; Psychopharmaceutical preparations for managing and treating diseases, disorders, and conditions related to HPA axis dysregulation, trauma, mood, thought, behavior, and perception; Psychedelic therapeutic preparations for treating and managing PTSD, eating disorders, postpartum depression, alcohol use disorder, opioid and substance use disorder, generalized anxiety disorder, social anxiety disorder, major depressive disorder, and traumatic brain injury.

Medical scientific research and development in the fields of psychotropics, psychedelic-assisted therapy, and psychopharmaceuticals; Providing medical scientific research information in the fields of psychotropics, psychedelic-assisted therapy, and psychopharmaceuticals.